Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome.

Standard

Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome. / Dörr, Jan; Radbruch, Helena; Bock, Markus; Wuerfel, Jens; Brüggemann, Anne; Wandinger, Klaus-Peter; Zeise, Daniel; Pfueller, Caspar F; Zipp, Frauke; Paul, Friedemann.

In: NAT REV NEUROL, Vol. 5, No. 12, 12, 2009, p. 683-688.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Dörr, J, Radbruch, H, Bock, M, Wuerfel, J, Brüggemann, A, Wandinger, K-P, Zeise, D, Pfueller, CF, Zipp, F & Paul, F 2009, 'Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome.', NAT REV NEUROL, vol. 5, no. 12, 12, pp. 683-688. <http://www.ncbi.nlm.nih.gov/pubmed/19953118?dopt=Citation>

APA

Dörr, J., Radbruch, H., Bock, M., Wuerfel, J., Brüggemann, A., Wandinger, K-P., Zeise, D., Pfueller, C. F., Zipp, F., & Paul, F. (2009). Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome. NAT REV NEUROL, 5(12), 683-688. [12]. http://www.ncbi.nlm.nih.gov/pubmed/19953118?dopt=Citation

Vancouver

Dörr J, Radbruch H, Bock M, Wuerfel J, Brüggemann A, Wandinger K-P et al. Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome. NAT REV NEUROL. 2009;5(12):683-688. 12.

Bibtex

@article{9cd7b43429164452a7475de04e1ee5ac,
title = "Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome.",
abstract = "BACKGROUND: A 23 year-old female presented to a neurology department with a 3 year history of recurrent episodes involving hearing loss, encephalopathy, focal neurological deficits, and visual field deficits. In the 3 years before presentation, the patient had been treated with methylprednisolone for suspected acute demyelinating encephalomyelitis and peripheral otogenic dysfunction from which she made a complete recovery, and for a visual defect in both eyes caused by bilateral branch retinal arterial occlusion, from which she partially improved and commenced long-term treatment with acetylsalicylic acid. INVESTIGATIONS: Detailed history, clinical examination, extensive laboratory work-up, cerebrospinal fluid analysis, cerebral and spinal MRI, periventricular single-voxel (1)H magnetic resonance spectroscopy, retinal fluorescence angiography, optical coherence tomography, audiometry, neurophysiological work-up (EEG, evoked potentials). DIAGNOSIS: Susac syndrome, characterized by a combination of encephalopathy, branch retinal artery occlusions, and hearing loss. MANAGEMENT: Long-term immunosuppressive treatment with azathioprine (150 mg/day) and prednisolone (10 mg/day), and inhibition of thrombocyte function with acetylsalicylic acid (100 mg/day).",
author = "Jan D{\"o}rr and Helena Radbruch and Markus Bock and Jens Wuerfel and Anne Br{\"u}ggemann and Klaus-Peter Wandinger and Daniel Zeise and Pfueller, {Caspar F} and Frauke Zipp and Friedemann Paul",
year = "2009",
language = "Deutsch",
volume = "5",
pages = "683--688",
journal = "NAT REV NEUROL",
issn = "1759-4758",
publisher = "NATURE PUBLISHING GROUP",
number = "12",

}

RIS

TY - JOUR

T1 - Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome.

AU - Dörr, Jan

AU - Radbruch, Helena

AU - Bock, Markus

AU - Wuerfel, Jens

AU - Brüggemann, Anne

AU - Wandinger, Klaus-Peter

AU - Zeise, Daniel

AU - Pfueller, Caspar F

AU - Zipp, Frauke

AU - Paul, Friedemann

PY - 2009

Y1 - 2009

N2 - BACKGROUND: A 23 year-old female presented to a neurology department with a 3 year history of recurrent episodes involving hearing loss, encephalopathy, focal neurological deficits, and visual field deficits. In the 3 years before presentation, the patient had been treated with methylprednisolone for suspected acute demyelinating encephalomyelitis and peripheral otogenic dysfunction from which she made a complete recovery, and for a visual defect in both eyes caused by bilateral branch retinal arterial occlusion, from which she partially improved and commenced long-term treatment with acetylsalicylic acid. INVESTIGATIONS: Detailed history, clinical examination, extensive laboratory work-up, cerebrospinal fluid analysis, cerebral and spinal MRI, periventricular single-voxel (1)H magnetic resonance spectroscopy, retinal fluorescence angiography, optical coherence tomography, audiometry, neurophysiological work-up (EEG, evoked potentials). DIAGNOSIS: Susac syndrome, characterized by a combination of encephalopathy, branch retinal artery occlusions, and hearing loss. MANAGEMENT: Long-term immunosuppressive treatment with azathioprine (150 mg/day) and prednisolone (10 mg/day), and inhibition of thrombocyte function with acetylsalicylic acid (100 mg/day).

AB - BACKGROUND: A 23 year-old female presented to a neurology department with a 3 year history of recurrent episodes involving hearing loss, encephalopathy, focal neurological deficits, and visual field deficits. In the 3 years before presentation, the patient had been treated with methylprednisolone for suspected acute demyelinating encephalomyelitis and peripheral otogenic dysfunction from which she made a complete recovery, and for a visual defect in both eyes caused by bilateral branch retinal arterial occlusion, from which she partially improved and commenced long-term treatment with acetylsalicylic acid. INVESTIGATIONS: Detailed history, clinical examination, extensive laboratory work-up, cerebrospinal fluid analysis, cerebral and spinal MRI, periventricular single-voxel (1)H magnetic resonance spectroscopy, retinal fluorescence angiography, optical coherence tomography, audiometry, neurophysiological work-up (EEG, evoked potentials). DIAGNOSIS: Susac syndrome, characterized by a combination of encephalopathy, branch retinal artery occlusions, and hearing loss. MANAGEMENT: Long-term immunosuppressive treatment with azathioprine (150 mg/day) and prednisolone (10 mg/day), and inhibition of thrombocyte function with acetylsalicylic acid (100 mg/day).

M3 - SCORING: Zeitschriftenaufsatz

VL - 5

SP - 683

EP - 688

JO - NAT REV NEUROL

JF - NAT REV NEUROL

SN - 1759-4758

IS - 12

M1 - 12

ER -